Citations (24)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (13)
Kuan-Wei Huang & Tiao-Lai Huang. (2023) Association between programmed death-1 pathway and major depression. The World Journal of Biological Psychiatry 24:9, pages 822-828.
Read now
Read now
Zhiqiang Yang & Fan He. (2023) An immune cell infiltration landscape classification to predict prognosis and immunotherapy effect in oral squamous cell carcinoma. Computer Methods in Biomechanics and Biomedical Engineering 0:0, pages 1-13.
Read now
Read now
Yutong He, Jin Shi, Bernd Schmidt, Qingyi Liu, Gaofeng Shi, Xiaoli Xu, Congmin Liu, Zhaoyu Gao, Tiantian Guo & Baoen Shan. (2020) Circulating Tumor Cells as a Biomarker to Assist Molecular Diagnosis for Early Stage Non-Small Cell Lung Cancer. Cancer Management and Research 12, pages 841-854.
Read now
Read now
Omar Abdel-Rahman, Hani Oweira & Anwar Giryes. (2018) Health-related quality of life in cancer patients treated with PD-(L)1 inhibitors: a systematic review. Expert Review of Anticancer Therapy 18:12, pages 1231-1239.
Read now
Read now
Peng-Fei Cui, Jun-Xun Ma, Fei-Xue Wang, Jing Zhang, Hai-Tao Tao & Yi Hu. (2017) Pneumonitis and pneumonitis-related death in cancer patients treated with programmed cell death-1 inhibitors: a systematic review and meta-analysis. Therapeutics and Clinical Risk Management 13, pages 1259-1271.
Read now
Read now
Xiangyi Kong & Yanguo Kong. (2017) Evidence from a meta-analysis: is nivolumabneurotoxic in cancer patients?. OncoTargets and Therapy 10, pages 1335-1344.
Read now
Read now
Yi Zheng, Yicheng Yang, Shu Wu, Yongqiang Zhu, Xiaolong Tang & Xiaopeng Liu. (2017) Combining MPDL3280A with adoptive cell immunotherapy exerts better antitumor effects against cervical cancer. Bioengineered 8:4, pages 367-373.
Read now
Read now
Mostafa Eltobgy, Hani Oweira, Ulf Petrausch, Daniel Helbling, Jan Schmidt, Arianeb Mehrabi, Othmar Schöb, Anwar Giryes, Michael Decker & Omar Abdel-Rahman. (2017) Immune-related neurological toxicities among solid tumor patients treated with immune checkpoint inhibitors: a systematic review. Expert Review of Neurotherapeutics 17:7, pages 725-736.
Read now
Read now
Jan Trøst Jørgensen. (2016) Companion diagnostic assays for PD-1/PD-L1 checkpoint inhibitors in NSCLC. Expert Review of Molecular Diagnostics 16:2, pages 131-133.
Read now
Read now
Thanashan Rajakulendran & David N Adam. (2015) Spotlight on pembrolizumab in the treatment of advanced melanoma. Drug Design, Development and Therapy 9, pages 2883-2886.
Read now
Read now
Tania Crombet Ramos, Pedro Camilo Rodríguez, Elia Neninger Vinageras, Beatriz Garcia Verdecia & Agustin Lage Davila. (2015) CIMAvax EGF (EGF-P64K) vaccine for the treatment of non-small-cell lung cancer. Expert Review of Vaccines 14:10, pages 1303-1311.
Read now
Read now
Omar Abdel-Rahman, Hesham ElHalawani & Mona Fouad. (2015) Risk of elevated transaminases in cancer patients treated with immune checkpoint inhibitors: a meta-analysis. Expert Opinion on Drug Safety 14:10, pages 1507-1518.
Read now
Read now
Peter Norman. (2015) Orphan drug approvals of 2014: Europe and the United States. Expert Opinion on Orphan Drugs 3:4, pages 445-455.
Read now
Read now
Articles from other publishers (11)
Xin Guo, Yuelin Zhang, Hengxing Jiao & Xingyu Miao. (2022) The prognostic significance of PD-L1 expression in patients with glioblastoma: A meta-analysis. Frontiers in Oncology 12.
Crossref
Crossref
Giandomenico Roviello, Martina Catalano, Raffaella Santi, Valeria Emma Palmieri, Gianmarco Vannini, Ilaria Camilla Galli, Eleonora Buttitta, Donata Villari, Virginia Rossi & Gabriella Nesi. (2021) Immune Checkpoint Inhibitors in Urothelial Bladder Cancer: State of the Art and Future Perspectives. Cancers 13:17, pages 4411.
Crossref
Crossref
Yujia Zhai, Reza Moosavi & Mingnan Chen. (2021) Immune Checkpoints, a Novel Class of Therapeutic Targets for Autoimmune Diseases. Frontiers in Immunology 12.
Crossref
Crossref
Chengyi Mao, Xiaoxi Zeng, Chao Zhang, Yushang Yang, Xin Xiao, Siyuan Luan, Yonggang Zhang & Yong Yuan. (2021) Mechanisms of Pharmaceutical Therapy and Drug Resistance in Esophageal Cancer. Frontiers in Cell and Developmental Biology 9.
Crossref
Crossref
Tsvetelina Velikova, Boris Krastev, Stefan Lozenov, Radostina Gencheva, Monika Peshevska-Sekulovska, Georgi Nikolaev & Milena Peruhova. (2021) Antibiotic-Related Changes in Microbiome: The Hidden Villain behind Colorectal Carcinoma Immunotherapy Failure. International Journal of Molecular Sciences 22:4, pages 1754.
Crossref
Crossref
Vincent Wuidar, Lionel Gillot, Isabelle Dias Da Silva, Alizée Lebeau, Anne Gallez & Christel Pequeux. 2021. Tumor Microenvironment. Tumor Microenvironment
499
533
.
Nayson L Fernandes, Soujanya Sodavarapu, Sukhmine Nedopil, Nikita Mohapatra & Dinesh Vyas. (2020) Checkpoint Inhibitor in a Melanoma Patient With Polyendocrinopathy and Gangrenous Gall Bladder With a Mass. Cureus.
Crossref
Crossref
Florian Guisier, Mateus Camargo Barros-Filho, Leigha D. Rock, Megan Strachan-Whaley, Erin A. Marshall, Graham Dellaire & Wan L. Lam. 2020. Tumor Microenvironment. Tumor Microenvironment
35
51
.
Yinan Dong, Qian Sun & Xinwei Zhang. (2016) PD-1 and its ligands are important immune checkpoints in cancer. Oncotarget 8:2, pages 2171-2186.
Crossref
Crossref
Qing Li, Nathan Johnston, Xiufen Zheng, Hongmei Wang, Xusheng Zhang, Dian Gao & Weiping Min. (2016) miR-28 modulates exhaustive differentiation of T cells through silencing programmed cell death-1 and regulating cytokine secretion. Oncotarget 7:33, pages 53735-53750.
Crossref
Crossref
Jing Zeng, Xin-Ke Zhang, Hua-Dong Chen, Zhi-Hai Zhong, Qiu-Liang Wu & Su-Xia Lin. (2016) Expression of programmed cell death-ligand 1 and its correlation with clinical outcomes in gliomas. Oncotarget 7:8, pages 8944-8955.
Crossref
Crossref